Satellite Subgenomic Particles Are Key Regulators of Adeno-Associated Virus Life Cycle
Open accessPublished version of a preprint
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Historically, adeno-associated virus (AAV)-defective interfering particles (DI) were known as abnormal virions arising from natural replication and encapsidation errors. Through single virion genome analysis, we revealed that a major category of DI particles contains a double-stranded DNA genome in a “snapback” configuration. The 5′- snapback genomes (SBGs) include the P5 promoters and partial rep gene sequences. The 3′-SBGs contains the capsid region. The molecular configuration of 5′-SBGs theoretically may allow double-stranded RNA transcription in their dimer configuration. Our studies demonstrated that 5-SBG regulated AAV rep expression and improved AAV packaging. In contrast, 3′-SBGs at its dimer configuration increased levels of cap protein. The generation and accumulation of 5′-SBGs and 3′-SBGs appears to be coordinated to balance the viral gene expression level. Therefore, the functions of 5′-SBGs and 3′-SBGs may help maximize the yield of AAV progenies. We postulate that AAV virus population behaved as a colony and utilizes its subgenomic particles to overcome the size limit of a viral genome and encodes additional essential functions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recombination between plus and minus strands during AAV replication may also form genomes that may express dsRNA upon transduction and second-strand formation.”
From Innate immune sensing of adeno-associated virus vectors (2024) · cites this paper as [54]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structural Basis for Double-Stranded RNA Processing by Dicer
MacRae, I. J., Zhou, K., Li, F., Repic, A., Brooks, A. N., Cande, W. Z., Adams, P. D., & Doudna, J. A. (2006) · Science · doi:10.1126/science.1121638 · Cited by 962 · cited 1×
“dsRNA is the precursor for RNA Interference [12], which would function as an inhibitor for the P5 promoter transcripts.”
BackgroundDNA helicase‐mediated packaging of adeno‐associated virus type 2 genomes into preformed capsids
King, J. A., Dubielzig, R., Grimm, D., & Kleinschmidt, J. A. (2001) · The EMBO Journal · doi:10.1093/emboj/20.12.3282 · Cited by 338 · cited 1×
“Since AAV packaging initiation starts from the 3′ITR, all ICGs have intact 3′ITR and no ICGs have 5′ITR [11].”
BackgroundRole for highly regulated rep gene expression in adeno-associated virus vector production
Li, J., Samulski, R. J., & Xiao, X. (1997) · Journal of Virology · doi:10.1128/jvi.71.7.5236-5243.1997 · Cited by 227
Self-citationAdeno-associated virus autointerference
Carter, B. J., LAUGHLIN, C. A., de la Maza, L. M., & Myers, M. W. (1979) · Virology · doi:10.1016/0042-6822(79)90149-1 · Cited by 115 · cited 1×
“Although the canonical AAV particle typically contains both ITRs and the entire coding region, AAV populations are often found to be heterogenous (3-7).”
BackgroundShort DNA Hairpins Compromise Recombinant Adeno-Associated Virus Genome Homogeneity
Xie, J., Mao, Q., Tai, P. W. L., He, R., Ai, J., Su, Q., Zhu, Y., Ma, H., Li, J., Gong, S., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.028 · Cited by 102
Defective-interfering particles of the human parvovirus adeno-associated virus
LAUGHLIN, C. A., Myers, M. W., Risin, D. L., & Carter, B. J. (1979) · Virology · doi:10.1016/0042-6822(79)90446-x · Cited by 82
Adeno-associated virus DNA replication: Nonunit-length molecules
Hauswirth, W. W., & Berns, K. I. (1979) · Virology · doi:10.1016/0042-6822(79)90275-7 · Cited by 77 · cited 2×
“Such a molecule was shown to be able to snap back and anneal to itself upon denaturing and renaturing cycle [6] SBGs are essentially a selfcomplementary DNA molecule with either the left moiety (5′-SBG) or the right moiety (3′-SBG) genomes.”
BackgroundNative Molecular State of Adeno-Associated Viral Vectors Revealed by Single-Molecule Sequencing
Kapranov, P., Chen, L., Dederich, D., Dong, B., He, J., Steinmann, K. E., Moore, A. R., Thompson, J. F., Milos, P. M., & Xiao, W. (2012) · Human Gene Therapy · doi:10.1089/hum.2011.160 · Cited by 60 · cited 1×
“AAV viruses were produced using the triple plasmid transfection system in HEK 293 cells according to method that were described previously [8].”
MethodSelf-citationTran, N. T., Heiner, C., Weber, K., Weiand, M., Wilmot, D., Xie, J., Wang, D., Brown, A., Manokaran, S., Su, Q., et al. (2020) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2020.07.007 · Cited by 58
Stutika, C., Gogol-Döring, A., Botschen, L., Mietzsch, M., Weger, S., Feldkamp, M., Chen, W., & Heilbronn, R. (2016) · Journal of Virology · doi:10.1128/jvi.02750-15 · Cited by 42 · cited 1×
“5’-SBG model theory and offer seamless interpretation of those observations (10).”
Background
Cited by
Tran, N. T., Lecomte, E., Saleun, S., Namkung, S., Robin, C., Weber, K., Devine, E., Blouin, V., Adjali, O., Ayuso, E., et al. (2022) · Human Gene Therapy · doi:10.1089/hum.2022.050 · Cited by 74
“51 In contrast, the short fragments in the rBV/Sf9-produced vector are smaller than 1 kb (Supplementary Fig.”
Innate immune sensing of adeno-associated virus vectors
Cao, D., Byrne, B. J., de Jong, Y. P., Terhorst, C., Duan, D., Herzog, R. W., & Kumar, S. R. P. (2024) · Human Gene Therapy · doi:10.1089/hum.2024.040 · Cited by 50
Stowaways in the cargo: Contaminating nucleic acids in rAAV preparations for gene therapy
Brimble, M. A., Winston, S. M., & Davidoff, A. M. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.07.025 · Cited by 45
Direct ITR-to-ITR Nanopore Sequencing of AAV Vector Genomes
Namkung, S., Tran, N. T., Manokaran, S., He, R., Su, Q., Xie, J., Gao, G., & Tai, P. W. L. (2022) · Human Gene Therapy · doi:10.1089/hum.2022.143 · Cited by 43
Zhang, J., Guo, P., Yu, X., Frabutt, D. A., Lam, A. K., Mulcrone, P. L., Chrzanowski, M., Firrman, J., Pouchnik, D. J., Sang, N., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.08.027 · Cited by 35
Self-citationThorough molecular configuration analysis of noncanonical AAV genomes in AAV vector preparations
Zhang, J., Yu, X., Chrzanowski, M., Tian, J., Pouchnik, D. J., Guo, P., Herzog, R. W., & Xiao, W. (2024) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2024.101215 · Cited by 15
Self-citationLkharrazi, A., Tobler, K., Marti, S., Bratus-Neuenschwander, A., Vogt, B., & Fraefel, C. (2024) · Journal of Virology · doi:10.1128/jvi.01282-24 · Cited by 12
Orthogonal characterization of rAAV9 reveals unexpected transgene heterogeneity
Eisenhut, P., Andorfer, P., Haid, A., Jokl, B., Manhartsberger, R., Fuchsberger, F. F., Innthaler, B., Lengler, J., Kraus, B., Pletzenauer, R., et al. (2024) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2024.07.020 · Cited by 9
Profiling AAV vector heterogeneity & contaminants using next-generation sequencing methods
Tran, N. T., & Tai, P. W. L. (2024) · Cell and Gene Therapy Insights · doi:10.18609/cgti.2023.206 · Cited by 7
Genomic Designs of rAAVs Contribute to Pathological Changes in the Livers and Spleens of Mice
Mulcrone, P. L., Zhang, J., Pride, P. M., Lam, A. K., Frabutt, D. A., Ball-Kell, S. M., & Xiao, W. (2022) · Advances in Cell and Gene Therapy · doi:10.1155/2022/6807904 · Cited by 7
“A triple plasmid cotransfection method was used to produce rAAVs as described previously [38, 39].”
BackgroundMethodInfluentialSelf-citationCampos, M., Otaegui, D., Jung, T., Bausewein, T., Fulin, J., Nordström, R., Toral, I., Silva-Ferrada, E. D., Нечаев, И. Н., Iribar, H., et al. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101530 · Cited by 6
“28 Finally, scAAV genomes add an additional complexity to this population of partial capsids by the presence of monomeric ssAAV.”
Recombinant Adeno-Associated Virus Production, the Beginning of the End of Uncertainty
Xiao, W., & Samulski, R. J. (2022) · Human Gene Therapy · doi:10.1089/hum.2022.29207.wxi · Cited by 2
“20 In contrast, erroneous packaging initiation will likely utilize nonstandard AAV packaging signal to initiate AAV encapsidation, which may result in viral particles containing genetic elements found in (1) the producer cell line ( i.e., host cellular DNA), (2) viral/ plasmid backbone, and/or (3)…”
Self-citationTalevich, E., Tseng, E., Diallo, A., Sellami, N., Elliott, A., Cantarel, B. L., Tonthat, N. K., Chatterjee, P., Tai, P. W. L., & Aldridge, C. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.07.592296 · Cited by 3
Gene delivery using viral vectors
Patel, D. H., Talele, D. R., & Talele, C. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27416-9.00010-1 · Cited by 2
Structural analysis of recombinant AAV vector genomes at single-molecule resolution
Rouleau, D., Lata, D., Dollive, S., Bruccoleri, R. E., van Lieshout, L. P., Golebiowski, D., & Iwuchukwu, I. (2026) · PLoS ONE · doi:10.1371/journal.pone.0339201 · Cited by 1
Metadata
- Authors
- Zhang, J., Yu, X., Guo, P., Firrman, J., Pouchnik, D., Diao, Y., Samulski, R. J., & Xiao, W.
- Affiliations
- Huaqiao University (CN)
- Agricultural Research Service (US)
- Temple University (US)
- University of North Carolina at Chapel Hill (US)
- Indiana University Indianapolis (US)
- Corresponding author
- Samulski, Richard Jude
- Xiao, Weidong
- ORCID
- Venue
- Viruses
- Publisher
- MDPI AG
- Published
- 2021-06-21
- Volume
- 13
- Issue
- 6
- Pages
- 1185
- ISSN
- 1999-4915 (ISSN-L)
- PMC
- PMC8235507
- OpenAlex
- W3175763316
- Cited by
- 15
- References
- 13
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 6 · 2023: 1 · 2022: 5
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Viruses (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- IUScholarWorks (Indiana University) (submittedVersion, cc-by)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Immunology and Microbiology › Virology › Bacteriophages and microbial interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Keywords
- adeno-associated virus, defective interfering particles, viral packaging, capsid protein, viral gene expression regulation
- MeSH terms
- Defective Interfering Viruses, Dependovirus, Humans, Life Cycle Stages, Viral Proteins, Virion, Virus Replication, Genome, Viral, Capsid Proteins, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.